旧版佛跳墙

旧版佛跳墙

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

旧版佛跳墙

Learn More
Folded page of a newspaper

旧版佛跳墙

旧版佛跳墙

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

旧版佛跳墙

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

旧版佛跳墙

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

旧版佛跳墙

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

旧版佛跳墙

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

旧版佛跳墙

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

天行vpm官网  芒果加速器下载安装 蓝光加速器  golink加速器 golink  mac vpn 知乎  迅豹vpn  洋葱jiasuqi加速器